These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33908322)

  • 1. 1,2,3,4-Tetrahydroisoquinoline (THIQ) as privileged scaffold for anticancer de novo drug design.
    Faheem ; Karan Kumar B; Venkata Gowri Chandra Sekhar K; Chander S; Kunjiappan S; Murugesan S
    Expert Opin Drug Discov; 2021 Oct; 16(10):1119-1147. PubMed ID: 33908322
    [No Abstract]   [Full Text] [Related]  

  • 2. Tetrahydroisoquinolines in therapeutics: a patent review (2010-2015).
    Singh IP; Shah P
    Expert Opin Ther Pat; 2017 Jan; 27(1):17-36. PubMed ID: 27623022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicinal chemistry perspectives of 1,2,3,4-tetrahydroisoquinoline analogs - biological activities and SAR studies.
    Faheem ; Karan Kumar B; Chandra Sekhar KVG; Chander S; Kunjiappan S; Murugesan S
    RSC Adv; 2021 Mar; 11(20):12254-12287. PubMed ID: 35423735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel tetrahydroisoquinoline-containing pyrimidines as ALK inhibitors.
    Achary R; Yun JI; Park CM; Mathi GR; Lee JY; Ha JD; Chae CH; Ahn S; Park CH; Lee CO; Hwang JY; Yun CS; Jung HJ; Cho SY; Kim HR; Kim P
    Bioorg Med Chem; 2016 Jan; 24(2):207-19. PubMed ID: 26712094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical Research on Antitumor Isoquinoline Marine Natural Products and Related Compounds.
    Saito N
    Chem Pharm Bull (Tokyo); 2021; 69(2):155-177. PubMed ID: 33518599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of an Acrylic Acid Based Tetrahydroisoquinoline as an Orally Bioavailable Selective Estrogen Receptor Degrader for ERα+ Breast Cancer.
    Burks HE; Abrams T; Kirby CA; Baird J; Fekete A; Hamann LG; Kim S; Lombardo F; Loo A; Lubicka D; Macchi K; McDonnell DP; Mishina Y; Norris JD; Nunez J; Saran C; Sun Y; Thomsen NM; Wang C; Wang J; Peukert S
    J Med Chem; 2017 Apr; 60(7):2790-2818. PubMed ID: 28296398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel tetrahydroisoquinoline (THIQ) analogue induces mitochondria-dependent apoptosis.
    Sun X; Liu M; Gao L; Mao Y; Zhao D; Zhuang J; Liu L
    Eur J Med Chem; 2018 Apr; 150():719-728. PubMed ID: 29573707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of novel tetrahydroisoquinoline-hydroxamate conjugates as potent dual SERDs/HDAC inhibitors for the treatment of breast cancer.
    Luo G; Lin X; Ren S; Wu S; Wang X; Ma L; Xiang H
    Eur J Med Chem; 2021 Dec; 226():113870. PubMed ID: 34610548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and Synthesis of Tetrahydroisoquinoline Derivatives as Anti-Angiogenesis and Anti-Cancer Agents.
    Gangapuram M; Eyunni S; Zhang W; Redda KK
    Anticancer Agents Med Chem; 2021; 21(18):2505-2511. PubMed ID: 33438560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromones: Privileged scaffold in anticancer drug discovery.
    Patil VM; Masand N; Verma S; Masand V
    Chem Biol Drug Des; 2021 Nov; 98(5):943-953. PubMed ID: 34519163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of quinoline as a privileged scaffold in cancer drug discovery.
    Musiol R
    Expert Opin Drug Discov; 2017 Jun; 12(6):583-597. PubMed ID: 28399679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of 3-substituted analogues of 1,2,3,4-tetrahydroisoquinoline as inhibitors of phenylethanolamine N-methyltransferase.
    Grunewald GL; Sall DJ; Monn JA
    J Med Chem; 1988 Apr; 31(4):824-30. PubMed ID: 3351861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and biological evaluation of potent 1,2,3,4-tetrahydroisoquinoline derivatives as anticancer agents targeting NF-κB signaling pathway.
    Sim S; Lee S; Ko S; Phuong Bui B; Linh Nguyen P; Cho J; Lee K; Kang JS; Jung JK; Lee H
    Bioorg Med Chem; 2021 Sep; 46():116371. PubMed ID: 34500188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A yeast platform for high-level synthesis of tetrahydroisoquinoline alkaloids.
    Pyne ME; Kevvai K; Grewal PS; Narcross L; Choi B; Bourgeois L; Dueber JE; Martin VJJ
    Nat Commun; 2020 Jul; 11(1):3337. PubMed ID: 32620756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the Goldilocks effect to the design of potent and selective inhibitors of phenylethanolamine N-methyltransferase: balancing pKa and steric effects in the optimization of 3-methyl-1,2,3,4-tetrahydroisoquinoline inhibitors by beta-fluorination.
    Grunewald GL; Seim MR; Lu J; Makboul M; Criscione KR
    J Med Chem; 2006 May; 49(10):2939-52. PubMed ID: 16686536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-Phenyl-1,2,3,4-tetrahydroisoquinoline: An Alternative Scaffold for the Design of 17β-Hydroxysteroid Dehydrogenase 1 Inhibitors.
    Mottinelli M; Sinreih M; Rižner TL; Leese MP; Potter BVL
    ChemMedChem; 2021 Jan; 16(1):259-291. PubMed ID: 33151004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymmetric synthesis of tetrahydroisoquinoline-fused spirooxindoles as Ras-GTP inhibitors that inhibit colon adenocarcinoma cell proliferation and invasion.
    Zhao Q; Peng C; Huang H; Liu SJ; Zhong YJ; Huang W; He G; Han B
    Chem Commun (Camb); 2018 Jul; 54(60):8359-8362. PubMed ID: 29993051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antitumor activity of cis-dichloroplatinum(II) complexes of 1-(2-aminophenyl)-1,2,3,4-tetrahydroisoquinolines.
    Kuo CY; Wu MJ; Kuo YH
    Eur J Med Chem; 2006 Aug; 41(8):940-9. PubMed ID: 16647164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of tetrahydroisoquinoline derivatives as potential multidrug resistance reversal agents in cancer.
    Li Y; Zhang HB; Huang WL; Li YM
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3652-5. PubMed ID: 18502125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based design and structure-activity relationships of 1,2,3,4-tetrahydroisoquinoline derivatives as potential PDE4 inhibitors.
    Liao Y; Guo Y; Li S; Wang L; Tang Y; Li T; Chen W; Zhong G; Song G
    Bioorg Med Chem Lett; 2018 Apr; 28(7):1188-1193. PubMed ID: 29545101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.